ADIPOQ and type 2 diabetes mellitus: Unlike other adipokines, adiponectin level is reduced in pathological conditions such as insulin resistance, type 2 diabetes mellitus (T2DM), obesity, metabolic syndrome, and cardiovascular diseases [1].